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Background:Aberrant origin of right subclavian arteries represents the
most common of the aortic arch anomalies. This variant has few published
series to guide management. Our goal was to review treatment options and
results for these potentially complex reconstructions.
Methods:A retrospective reviewwas performed on all patients with the
diagnosis of aberrant right subclavian artery at our institution from January
2003 through July 2009.
Results: Nineteen patients, comprising one of the largest series re-
ported, including 9 males and 10 females (mean age, 40.6 years; range,
7-77), were diagnosed with an aberrant right subclavian artery. The diag-
nosis was incidental in 14 (74%), but 5 (26%) had symptoms of dysphagia or
upper extremity ischemia, or both. The diagnosis was established by com-
puted tomography in 15 patients (79%), by magnetic resonance imaging in
3 (15%), and by standard angiography in 1 (5%). The most common
associated anomaly was a Kommerell’s diverticulum (KD), which was found
in five patients (26%), all of whom required intervention for symptoms or
aneurysmal degeneration. Intervention was performed in 10 patients (53%),
including carotid subclavian bypass in 5 (50%), carotid subclavian transpo-
sition in 3 (30%), and ascending aorta to subclavian bypass in 2 (20%). Four
patients (40%) had additional intervention for management of aneurysmal
disease of the aorta or KD, with open aortic replacement in two (20%) and
aortic endografting in two (20%). There was one perioperative death (10%)
in a patient undergoing aortic arch debranching with placement of an aortic
endograft. Eighteen patients were alive without symptoms after a mean
follow-up of 38 months.
Conclusions: Aberrant right subclavian arteries are most commonly
found incidentally with computed tomography. The presence of a KD
appeared to correlate with the need for intervention. Patients with no
symptoms with the absence of a KD can safely be followed.
Fig. Regions vulnerable to microemboli
Table. Patency, limb salvage, and survival rates
1 Mon (%) 3 Mon (%) 6
Primary 89.5 79.6
Primary assisted 91.5 82.2
Secondary 94.9 90.0
Limb salvage 96.3 92.7
Survival 96.7 89.9 86.1Clinical Outcomes and Implications of Failed Infrainguinal Endovas-
cular Stents
Ilia Gur, MD, William Lee, Fred A. Weaver, MD, Vincent L. Rowe, MD,
Gabriel Akopian, and Steven G. Katz, MD, Vascular Surgery, USC, Pasa-
dena, CA, Pasadena, CA, and Los Angeles, CA
Objective: Although the influence of initial TASC II classification has
been clearly shown to influence the primary patency of infrainguinal stenting
procedures, its effect on outcomes once stent failure has occurred is less well
documented. It is the objective of this paper to determine whether clinical
outcomes and implications of anatomic stent failure vary according to initial
TASC II classification
Methods:Results were analyzed by TASC II classification. Kaplan-
Meier survival curves were plotted, and differences between groups tested by
log-rank method. A Cox proportional hazards regression model was used to
perform the multivariate analysis
Results: During a 5-year period, 239 angioplasties and stents were
performed in 192 patients. Primary patency was lost in 69 stented arteries.
Failure was due to one or more hemodynamically significant stenoses in 43
patients and occlusion in 26. After primary stenting, limbs initially classified
as TASC C and D were more likely to fail with occlusion (P  .0001),
require open operation (P  .032), or lose runoff vessels (P  .0034) than
those classified as TASCA or B. In two patients initially classified as TASCC,
stent failure changed the level of the open operation to a more distal site.
Percutaneous reintervention was performed on 35 limbs. Successful reinterven-
tion improved the patency of TASC A and B lesions to 92%, 85%, and 64% and
TASC C and D lesions to 78%, 72%, and 50% at 12, 24, and 36 months,
respectively. Initial TASC classification was highly predictive of first anatomic
failure (P  .0001) but did not predict the durability of subsequent catheter
based reintervention (P .32). Ten patients with stent failure required opera-
tion, and five underwent amputation; all had failed with occlusion. Overall limb
salvage was 89% and periprocedural mortality was 0.4%.
Conclusions: After primary stenting of the SFA and popliteal artery,
lesions classified as TASC C or D are more likely to fail with occlusion, lose
runoff vessels, and alter the site of subsequent open operation than their
TASC A and B counterparts. Although these complications are infrequent,
they may negatively impact later attempts at revascularization and this must
be considered when deciding on the proper treatment strategy for patients
with infrainguinal occlusive disease.
Intraoperative Thrombolysis and Laser Atherectomy: Effective Treat-
ment for TASC C and D Lesions in Critical Limb Ischemia
Sam S. Ahn, MD, Kenneth R. Kollmeyer, MD, Foster A. Hays, Julia F.
Chen, Craig A. Ferrara, MD, Pablo V. Uceda, MD, and Robert W. Feldt-
man, MD, DFW Vascular Group, Dallas, TX, and Dallas, TX
Objective: We postulate that catheter-directed intraoperative throm-
bolysis in conjunction with laser atherectomy is a safe and effective treatment
of TASC C and D critical limb ischemia.
Methods: We retrospectively analyzed 411 patients who underwent
670 percutaneous, lower extremity interventions from September 2004 to
October 2009. Indications for intervention were limb salvage (98.7%) and
claudication (1.3%). TASC C lesions were present in 40.9% of patients and
TASC D lesions in 59.1%. Gender was 51.0% male and 49.0% female.
Average age was 69.5  12.0 years (range, 30-97 years). Risk factors
included hypertension (87.8%), diabetes (70.2%), coronary artery disease
(56.4%), tobacco abuse (54.8%), hyperlipidemia (49.4%), COPD (36.6%),
congestive heart failure (26.3%), renal insufficiency (23.7%), history of
myocardial infarction (21.3%), history of TIA or CVA (20.0%), atrial fibril-
lation (16.6%), dialysis (16.0%), morbid obesity (14.9%), arrhythmia (7.3%),
and pacemaker (6.1%). All procedures involved catheter-directed arterial
infusion of 2 to 10 mg of tissue plasminogen activator into the lesion and
laser atherectomy: 647 extremities required balloon angioplasty, and 326
extremities required stenting. Technical success required completion of the
intended procedure. Clinical success required no deaths, strokes, myocardial
infarctions, bleeding requiring transfusion, thromboemboli, infection, respi-
ratory complications, or reinterventions within 30 days. Follow-up was at 24
hours, 30 days, 6 months, and then every 6 months. Kaplan-Meier analysis
was used for patency, limb salvage, and survival rates.
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